Strata Critical Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Strata Critical Medical, Inc. (SRTA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Sep 2021
Operating Activities
Net Income-27.31-56.08-27.26-40.05
Depreciation & Amortization5.967.115.730.60
Deferred Income Tax-0.26-1.47-0.77-3.64
Stock Based Compensation19.8912.508.289.62
Change in Working Capital-3.01-6.74-0.02-2.20
Change in Accounts Receivable-1.00-10.25-5.35-0.41
Change in Accounts Payable-8.349.059.901.96
Change in Other Working Capital6.45-5.65-1.091.73
Other Operating Activities-4.15-10.06-1.091.73
Net Cash from Operating Activities-2.52-32.35-37.13-15.62
Investing Activities
Capital Expenditures-30.88-2.11-0.73-0.80
Acquisitions-2.23-0.04-48.29-23.07
Purchases of Investments34.2019.06-228.02-308.77
Sales/Maturities of Investments-2.1220.40356.3811.30
Other Investing Activities-2.110.000.000.00
Net Cash from Investing Activities-1.0217.0979.34-321.34
Financing Activities
Debt Repayment0.000.000.00-1.17
Common Stock Issued0.170.070.09119.63
Common Stock Repurchased-5.93-0.15-1.17-0.05
Other Financing Activities-5.68-0.15-1.17213.65
Net Cash from Financing Activities-5.76-0.08-1.08332.26
Summary
Effect of Forex Changes on Cash-0.08-0.070.070.00
Net Change in Cash-9.37-15.4041.13-4.69
Cash at Beginning of Period29.0244.423.2312.28
Cash at End of Period19.65-13.9644.427.58
Free Cash Flow-33.39-34.46-37.86-16.42
Supplemental Disclosures
Interest Paid0.000.000.000.01
Income Taxes Paid0.000.020.000.00